Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,146 | 913 | 99.6% |
| Education | $56.76 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,471 | 247 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,109 | 169 | $0 (2024) |
| Janssen Biotech, Inc. | $975.59 | 82 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $965.73 | 63 | $0 (2024) |
| Gilead Sciences, Inc. | $883.71 | 79 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $586.40 | 27 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $405.54 | 18 | $0 (2024) |
| PFIZER INC. | $352.06 | 20 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $350.66 | 18 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $290.36 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,677 | 166 | ABBVIE INC. ($641.40) |
| 2023 | $2,779 | 175 | ABBVIE INC. ($660.83) |
| 2022 | $2,132 | 133 | Takeda Pharmaceuticals U.S.A., Inc. ($575.61) |
| 2021 | $1,506 | 100 | AbbVie Inc. ($448.10) |
| 2020 | $807.81 | 56 | AbbVie Inc. ($219.46) |
| 2019 | $1,413 | 114 | AbbVie, Inc. ($507.39) |
| 2018 | $1,026 | 100 | AbbVie, Inc. ($266.25) |
| 2017 | $861.95 | 72 | AbbVie, Inc. ($268.07) |
All Payment Transactions
916 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $38.45 | General |
| 12/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.05 | General |
| 11/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: GI | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 562 | 592 | $671,089 | $63,718 |
| 2022 | 12 | 585 | 625 | $414,208 | $68,939 |
| 2021 | 12 | 583 | 616 | $395,556 | $64,924 |
| 2020 | 14 | 667 | 780 | $401,549 | $59,015 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 113 | 116 | $197,104 | $22,797 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 103 | $49,654 | $9,345 | 18.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 101 | 106 | $146,396 | $6,671 | 4.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $27,315 | $4,512 | 16.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $74,830 | $4,466 | 6.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 62 | $21,409 | $4,183 | 19.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 32 | 32 | $47,493 | $3,124 | 6.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $16,762 | $3,072 | 18.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $20,915 | $2,725 | 13.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 12 | $48,974 | $1,293 | 2.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $18,191 | $1,214 | 6.7% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 14 | 14 | $2,045 | $316.68 | 15.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 94 | 121 | $24,960 | $14,720 | 59.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 78 | 79 | $101,515 | $14,531 | 14.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 131 | 139 | $88,265 | $8,644 | 9.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $68,517 | $7,694 | 11.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 47 | 51 | $49,725 | $5,944 | 12.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $9,757 | $4,544 | 46.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $39,732 | $4,385 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 33 | $5,040 | $2,804 | 55.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 15 | 15 | $13,860 | $2,530 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,423 | $1,689 | 49.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $7,514 | $1,058 | 14.1% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 20 | 20 | $1,900 | $396.41 | 20.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 65 | 68 | $87,380 | $12,596 | 14.4% |
About Dr. Michael Pappas, MD
Dr. Michael Pappas, MD is a Gastroenterology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437110442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Pappas, MD has received a total of $13,203 in payments from pharmaceutical and medical device companies, with $2,677 received in 2024. These payments were reported across 916 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($13,146).
As a Medicare-enrolled provider, Pappas has provided services to 2,397 Medicare beneficiaries, totaling 2,613 services with total Medicare billing of $256,597. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Toledo, OH
- Active Since 03/29/2006
- Last Updated 09/24/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1437110442
Products in Payments
- ENTYVIO (Biological) $1,425
- XIFAXAN (Drug) $808.77
- STELARA (Biological) $791.24
- RINVOQ (Biological) $731.48
- Humira (Biological) $706.14
- ZENPEP (Drug) $641.30
- HUMIRA (Biological) $548.45
- GATTEX (Drug) $516.13
- SKYRIZI (Biological) $493.86
- DUPIXENT (Biological) $405.54
- OCALIVA (Drug) $350.66
- XELJANZ (Drug) $340.06
- LINZESS (Drug) $305.86
- ZEPOSIA (Drug) $262.46
- Cimzia (Drug) $205.60
- VIBERZI (Drug) $197.62
- INJECTAFER (Drug) $182.76
- Mavyret (Drug) $176.10
- CREON (Drug) $169.58
- CLENPIQ (Drug) $157.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toledo
Scott Corman, D.o, D.O
Gastroenterology — Payments: $13,759
Dr. David Zack, D.o, D.O
Gastroenterology — Payments: $10,695
Kevin Koffel, M.d, M.D
Gastroenterology — Payments: $3,954
Dr. Benjamin Hart, M.d, M.D
Gastroenterology — Payments: $3,401
Dr. Sapna Reddy, Md, MD
Gastroenterology — Payments: $2,142
Dr. Muhammad Aziz, Mbbs, MBBS
Gastroenterology — Payments: $1,820